Inovio (INO) Pharmaceuticals announced the pricing of an underwritten public offering of 13,158,000 shares of its common stock at a public offering price of $1.90 per share. All of the shares of common stock in the offering are being sold by Inovio. The offering is expected to close on or about November 12. Piper Sandler & Co. is acting as sole manager for the offering.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INO:
- Inovio Pharmaceuticals Reports Q3 2025 Financial Results
- Inovio announces common stock offering, no amount given
- Inovio reports Q3 EPS (87c), consensus (48c)
- Options Volatility and Implied Earnings Moves Today, November 10, 2025
- Options Volatility and Implied Earnings Moves This Week, November 10 – November 14, 2025